Translational Research Initiative for Hearing (TRIH)

Our Translational Research Initiative for Hearing (TRIH) Grant aims to help strengthen the translation of fundamental research towards patient benefit. This year, applications will be accepted in the following areas:

Small molecule, gene or cell-based approaches for the treatment of hearing loss or tinnitus.

Research that addresses at least one of the following “TRIH Challenge” topics: Validation of therapeutic targets for the treatment of hearing loss or tinnitus; Studies to strengthen confidence that a target or therapeutic approach will be applicable to human hearing loss or tinnitus; Preclinical model validation.

Funding: £100,000 per year 

Duration: 3 years

EOI (required) due date: 3.5.16

Full proposal due date: TBD